Nimodipine

In the US, Nimodipine (nimodipine systemic) is a member of the drug class calcium channel blocking agents and is used to treat Ischemic Stroke, Migraine Prevention and Subarachnoid Hemorrhage.

US matches:

Scheme

Rec.INN

ATC (Anatomical Therapeutic Chemical Classification)

C08CA06

CAS registry number (Chemical Abstracts Service)

0066085-59-4

Chemical Formula

C21-H26-N2-O7

Molecular Weight

418

Therapeutic Categories

Calcium channel blocker

Cerebral vasodilator

Treatment of cerebrovascular disorders

Chemical Name

3,5-Pyridinedicarboxylic acid, 1,4-dihydro-2,6-dimethyl-4-(3-nitrophenyl)-, 2-methoxyethyl 1-methylethyl ester

Foreign Names

Generic Names

  • Nimodipina (OS: DCIT)
  • Nimodipine (OS: DCF, USAN, BAN)
  • Bay e 9736 (IS: Bayer)
  • NMDP (IS)
  • Nimodipin (PH: Ph. Eur. 7)
  • Nimodipine (PH: BP 2011, Ph. Eur. 7, USP 34)
  • Nimodipinum (PH: Ph. Eur. 7)

Brand Names

International Drug Name Search

Glossary

TermDefinition
BANBritish Approved Name
DCFDénomination Commune Française
DCITDenominazione Comune Italiana
ISInofficial Synonym
OSOfficial Synonym
PHPharmacopoeia Name
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name

Click for further information on drug naming conventions and International Nonproprietary Names.

Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Hide
(web1)